BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  BioMidwest

  Biopharma Money on the Move: December 16-22

  A roundup of the latest biopharma companies scooping up cash through IPOs and financing rounds.

  December 23, 2020

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Bristol Myers Squibb’s Opdivo Brain Tumor Trial Fails Mid-Trial Assessment

  As a result, the company has decided to unblind the treatment assignments of patients in the trial.

  December 23, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Beach

  Neomorph to Leverage $109 Million Series A Funds Against Undruggable Targets

  It is already a very Merry Christmas for brand new San Diego-based biotech Neomorph, Inc., which found $109 million under the tree in a Series A financing to advance its proprietary protein degradation platform and programs.

  December 23, 2020

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Voyager Takes a Hit After FDA Places Hold on Gene Therapy for Parkinson’s Disease

  In October, the FDA placed a clinical hold on the company’s Huntington’s disease gene therapy before that asset could make its way into the clinic.

  December 23, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Trump Pardons Former Congressman Convicted of Insider Trading of Pharma Stock

  Former U.S. Rep. Chris Collins spent less than a year in federal prison for pleading guilty to violating felony insider trading laws when he sat on the board of directors of Innate Therapeutics. On Tuesday, Collins received a pardon from President Donald Trump.

  December 23, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  Clinical Catch-Up: December 21-25

  Even with the holidays among us, there were a number of clinical trial announcements. Here’s a look.

  December 23, 2020

   · 

  9 min read

   · 

  Mark Terry
• 

  Drug Development

  Therapeutics for ‘COVID-19 Long-Haulers’ Exploding onto the Scene as 2020 Ends

  BioSpace spoke with just a couple of companies endeavoring to make 2021 a happier new year for survivors now suffering from the life-altering after-effects of COVID-19.

  December 23, 2020

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Global Roundup: EU Approves ViiV’s HIV-1 Drug and More

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  December 23, 2020

   · 

  7 min read

   · 

  Alex Keown
• 

  Policy

  U.S. Government Secures 100 Million More Pfizer-BioNTech COVID-19 Vaccine Doses

  Yesterday it was reported that the two companies were working to make more of their vaccine than the 1.3 billion it promised to manufacture in 2021.

  December 23, 2020

   · 

  6 min read

   · 

  Mark Terry
• 

  Job Trends

  Twist Bioscience Plans to Bring 400 Jobs to Oregon with New State-of-the-Art Facility

  The new state-of-the-art facility, dubbed the “Factory of the Future,” will span 110,000 square feet and will be located in the city of Wilsonville, Oregon.

  December 23, 2020

   · 

  3 min read

   · 

  Brandon May